Company intelligence / Profile preview

Elsa Science

Ownership: Private
Employees: ~12
Development stage: Commercial

Overview

Elsa Science offers a digital companion application designed to help people with rheumatoid arthritis manage their condition through symptom tracking, medication management, and cognitive behavioral therapy-based health programs. The platform aims to improve quality of life by supporting self-management and facilitating data sharing between patients, healthcare providers, researchers, and industry partners. Clinical results are not applicable as this is a digital health tool rather than a pharmaceutical product.

Therapeutic areas: OtherImmunology
Modalities: Non-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

Collaborates with patient organizationsHealthcare professionalsScientists from Karolinska InstitutetOthers in co-development of the platform

Beyond the preview

Go deeper on Elsa Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elsa Science.

Explore the full profile